Abbott Laboratories
Search results
May 7, 2024 · AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives.
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74.
AbbVie | Pharmaceutical Research & Development. Inventing the Future of Medicine. By investing in groundbreaking technologies, we’re on a mission to deliver better solutions to patients. Learn more. Pipeline. Advancing medicines with strong clinical performance in areas of great need. Focus Areas.
When we became our own company, AbbVie formed a new kind of enterprise—a biopharmaceutical company. We blend the stability, global scale, resources and commercial capabilities of a pharmaceutical company with the focus and culture of a biotech.
Apr 18, 2022 · AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives.
At AbbVie, we combine advanced science, expertise and passion to solve serious health issues and have a remarkable impact on people’s lives. We are committed to improving health care in markets where we operate. Passionate about our work. Responsible for our actions.
Jul 12, 2024 · AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Giant Cell Arteritis. Submissions are supported by the Phase 3 SELECT-GCA study demonstrating upadacitinib 15 mg with a 26-week steroid taper regimen achieved the primary endpoint of sustained remission from week 12... July 10, 2024.
May 8, 2020 · May 08, 2020. AbbVie Completes Transformative Acquisition of Allergan. - Creates biopharmaceutical company with leadership positions in key therapeutic areas: Immunology, Hematologic Oncology, Neuroscience, and Allergan Aesthetics. - Robust portfolio of on-market and pipeline assets well-positioned for sustainable long-term growth.
Nov 30, 2023 · The acquisition accelerates AbbVie's commercial and clinical presence in the solid tumor space. Additionally, ImmunoGen's follow-on pipeline of promising next-generation ADCs further complements AbbVie's ADC platform and existing programs.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early...
